Dakang Medical (DiaCare Medical), a Beijing-based provider of blood purification chain medical services, has reportedly raised RMB 400 million (USD 59.7 million) in a Series E financing round, the largest deal in the segment. The round was led by Jiangxi Ganjiang New District Development and Investment Group Co., Ltd, with contributions from Central Enterprises Poor Regions Industry Investment Fund Co., Ltd and Neovision Capital.
Post – Financing Plans
According to the source, Dakang Medical will carry out industry mergers and acquisitions following the financing round. The company aims to expand private hemodialysis centers in China.-Fineline Info & Tech
